GDC-1971
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GDC-1971, covering 2025-07-03 to 2025-11-13. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal Cancer [Phase 1]